# EPIVIR-HBV
> **NDA021004** · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1998-12-08
## Drug
- **FDA Application Number:** NDA021004
- **Application type:** New Drug Application
- **Brand name:** EPIVIR-HBV
- **Generic name:** Lamivudine
- **Active ingredients:** LAMIVUDINE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** GLAXOSMITHKLINE
- **First approval:** 1998-12-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021004)
---
*AI Analytics · CC0 1.0*